TP53 and breast cancer: RGZ also increased the binding of PPARγ to the NF-κB sequence on the promoter sequence of p53, upregulated the expression level of p53 in MCF7, induced caspase 9 cleavage and DNA fragmentation, triggered the apoptotic pathway, stopped the growth, and promoted apoptosis of breast cancer cells [187].